Drug Screening Highlights: Let’s Learn Together
Drug Testing: True or False? | Part 3 of 4
Do FDA-Cleared and CLIA-Waived Mean the Same Thing?
You're reviewing two drug testing products for your organization. One is labeled FDA-cleared. The other is labeled CLIA-waived.
Both sound official. Both involve regulatory oversight.
So, do they mean the same thing?
True or False?
The answer: False.
Although FDA clearance and CLIA-waived status are related to diagnostic testing, they describe different regulatory concepts.
FDA clearance generally means the FDA has reviewed a medical device through an applicable regulatory pathway and determined that it meets the requirements for marketing, including its intended use.
CLIA-waived status, on the other hand, refers to certain laboratory tests categorized as simple to perform with a low risk of an incorrect result when used according to their instructions.
Here's where it gets interesting.
A drug test may be FDA-cleared without being CLIA-waived. And CLIA-waived status doesn't mean a product is automatically appropriate for every testing environment or purpose.
For healthcare clinics, treatment centers, and other organizations conducting drug screening, these distinctions can influence which products are appropriate for their testing programs.
Before purchasing, review the manufacturer's instructions, intended use, and applicable regulatory requirements.
The right product isn't simply the one with the most regulatory terminology on its packaging. It's the one that fits your organization's testing needs.
Fact Friday takeaway:
FDA-cleared and CLIA-waived describe different regulatory concepts. Understanding both helps organizations evaluate drug testing products and their intended uses.
Using a credible resource for drug screening supplies helps support consistency and reliability across your program.
